Evaluating a novel cardioprotective agent against DOX-induced cardiotoxicity in transgenic zebrafish model
Doxorubicin (DOX) is an anticancer drug which has been widely used and become one of the most prescribed antineoplastic agent due to its high efficacy in fighting a wide array of cancers. However, its usage is greatly limited by its well-known side effect, cardiotoxicity. DOX-induced cardiotoxicity...
Saved in:
Main Author: | Wong, Sze Ching |
---|---|
Other Authors: | Luo Qian, Kathy |
Format: | Final Year Project |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/64757 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Investigating the toxicity of ATA nanoparticles in vitro and cardioprotective effects of ATA on DOX-induced cardiotoxicity in zebrafish
by: Lee, Eden Hui Ling
Published: (2015) -
Establishing a scientific visualization framework to assess drug-induced cardiotoxicity using transgenic zebrafish
by: Ismail Osman
Published: (2014) -
Mollification of doxorubicin (DOX)-mediated cardiotoxicity using conjugated chitosan nanoparticles with supplementation of propionic acid
by: Siva, Durairaj, et al.
Published: (2022) -
Pharmacologically induced angiogenesis in transgenic zebrafish
by: Raghunath, M., et al.
Published: (2014) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
by: Cheah, Irwin K, et al.
Published: (2023)